Modafinil for the treatment of methamphetamine dependence - Wikidata - awgldk - TriplyDB

Modafinil for the treatment of methamphetamine dependence

Modafinil for the treatment of methamphetamine dependence

http://www.wikidata.org/entity/Q35583271

about

Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions Future pharmacological treatments for substance use disorders Efficacy of psychostimulant drugs for amphetamine abuse or dependence R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse Pharmacotherapy for stimulant-related disorders Pharmacotherapy of amphetamine-type stimulant dependence: an update Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers.Biologic Approaches to Treat Substance-Use Disorders Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development Pharmacological treatments for methamphetamine addiction: current status and future directions.Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Psychostimulant addiction treatment.Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis Tryptophan for the sleeping disorder and mental symptom of new-type drug dependence: A randomized, double-blind, placebo-controlled trial.Mitigating the Effects of Nonadherence in Clinical Trials.Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Methamphetamine-Related Disorders.A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials.Methylphenidate vs. resperidone in treatment of methamphetamine dependence: A clinical trial.Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata.The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.

P2860

Q21129426-B5F047AD-136F-4E5B-9622-BD74F62FFD76 Q22242633-38521885-C6EE-4748-9C9D-37DEBEC5DC03 Q24198261-B7D6C120-ED46-42A5-ABF6-E0258DF5BD6C Q24621917-ACD2EBEE-14A7-43CE-969D-303475E27C66 Q26829186-4D292784-92A9-4FE1-97FF-D8A841FBE521 Q26991936-BF20C628-A59D-4B78-B404-C7FD48E9EADD Q26996339-4C2F9B96-0951-49FF-A63E-8A3C07F0D126 Q27308084-3EA086ED-463D-437F-80F8-E200532A7C58 Q28085073-5FC4C8F0-922A-4F1E-B44A-1F87130106CC Q28088434-6E66B72A-21E1-42D6-85BF-435B07E00677 Q30240173-11E799D8-E637-4316-9C70-536ACC323122 Q34021980-39E002F6-4B75-47F3-B47B-2BEF98075695 Q34149087-C44D71AB-C1C4-4DE1-845E-C610CD639812 Q34181746-E92968D9-45C6-4722-98C1-875E1A431B7D Q34219147-E7C2A3A8-EE6D-4E0D-B3EC-A3AD3C1F0E49 Q34315501-D93BA84B-9968-4482-BD3A-85EBF294771B Q34363257-5AF8A7FE-6C31-4DC5-AE8E-4A4BBD447893 Q34494307-107ED35A-33A5-4D03-B50E-92EA07C817A9 Q35298970-D848BC22-5C67-409F-AA80-7CF3A4803E96 Q35576598-B69AD6D1-1291-46F5-BB03-FCFB6746B0B5 Q35915231-8B723B94-5A41-4B19-9DFB-6F0C7A5956DB Q36030946-1FCACC77-A544-4B2A-A50C-DED21F77E692 Q36090479-716FF8A0-A117-422E-B30C-752FD5D059DA Q36192104-338BC7DA-5E87-43C3-A5CF-C504975AAEDE Q36338815-BF3DB158-F0DC-4F88-B41F-34A4583A6914 Q36698847-1228F26B-49C4-4400-9004-F32D7EBD5AC9 Q36813681-BD9B5A5A-443F-46B2-8A0C-17DE557C2513 Q36977149-5616CA18-244D-4CB1-869A-E27EE9011039 Q37024852-4E6208DD-D510-47E9-846E-E2D8CC9DBD4B Q37062547-A9B4EAE9-750E-4A47-88E8-F2D1911EF4F0 Q37116798-BD2291CE-0A53-4F56-8226-FAFA884A28CA Q37344145-C8C4BDCC-2107-4BE3-A54B-9EC69A4CB90B Q37418649-F2B16D6B-A3F6-46FA-8822-3F9990459280 Q39034288-A9BE6B18-FBB8-41A7-9E1B-F5AB5DC34419 Q39433370-A4CE44C7-D229-465A-875B-28557B25F28D Q41767627-191C881D-3AEF-42AB-9DC2-EA21E22C75B8 Q42736836-2EC37AD8-1F0E-4DB4-BEB4-5FD93886D82E Q46202005-1CE3917A-FBEC-4A69-9C62-A2A8762EB608 Q48156370-81CC65D9-035C-40CE-9DFB-0CB38D28820D Q50023810-22CC4B2D-53C2-4732-BCE1-B3D455554E24

P2860

Modafinil for the treatment of methamphetamine dependence

http://www.wikidata.org/entity/Q35583271

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Modafinil for the treatment of methamphetamine dependence

@ast

Modafinil for the treatment of methamphetamine dependence

@en

type

label

Modafinil for the treatment of methamphetamine dependence

@ast

Modafinil for the treatment of methamphetamine dependence

@en

prefLabel

Modafinil for the treatment of methamphetamine dependence

@ast

Modafinil for the treatment of methamphetamine dependence

@en

P1433

Q35583271-B3E35069-0114-4DC4-8F15-E3E9ABED5352

P1476

Q35583271-8EA5E5B8-209A-4A7B-8AB1-827FB8C96964

P2093

Q35583271-031930F3-A793-4302-8E98-DEEC0BA8A3FC

Q35583271-05D500AC-34FA-41FB-8C4B-14D23BABA3DF

Q35583271-0B0C4649-BF5E-46B9-8C97-BB1DADD819FD

Q35583271-0EE40AB1-B798-46A8-8EF6-45C5FDBC82E9

Q35583271-1E678AFD-B5CA-4612-9774-784989A3C44A

Q35583271-237E6650-EED0-4FC9-B221-A4342DF6B99E

Q35583271-253778EC-CE59-4B39-9DEC-3CC41ED50A5F

Q35583271-701B2E42-3011-4C6A-83D3-69E1F297AC92

Q35583271-7C8B3899-1346-49A2-863A-F0D6AE2FD71F

Q35583271-7E6602CD-9776-47D0-941D-621DF486F841

P2860

Q35583271-0830531B-7418-4BAF-A485-F4E90D308D53

Q35583271-0E289416-DFF5-4200-A0DF-A84E036F912E

Q35583271-1F7388DC-7D4C-41A2-A0D1-F8BA34CFC79E

Q35583271-24C326A3-2AB5-4A71-A2C2-CAF4D0ECE953

Q35583271-2F51F825-979B-4277-AE88-063620818713

Q35583271-3DF27973-E017-42E1-89B2-23320A7D0A4F

Q35583271-6956F8D1-9B73-4C4F-A15E-22D6E7FB7FDE

Q35583271-6DC7BA88-7E09-4495-A914-C369A8C6C917

Q35583271-716E1507-E1A4-44CD-8806-668FBDAF8648

Q35583271-735E45F5-DAD4-42C0-9256-9B36607E9A56

P304

Q35583271-05E01F57-824B-4385-B595-50FCC45E8641

P31

Q35583271-819E7993-4F2B-46BE-A439-FF8F17EA5C22

P356

Q35583271-16EF9F4E-94E3-4EB0-BB16-FAF03E61B8A2

P433

Q35583271-FD46871D-CD57-400E-B3D1-056E36C38E51

P478

Q35583271-A5182D8D-1759-4ADA-BAFF-643A04B3CC6A

P50

Q35583271-61C404E0-0723-49CB-95E7-5E25291A34B2

P577

Q35583271-F972417D-C70A-453D-AE27-D77EE9C4E95A

P5875

Q35583271-B03591B1-DEAC-4A8E-9042-0A66EC4B4597

P698

Q35583271-F02BE9C4-3BC5-4C9E-A070-C692D7D747C2

P921

Q35583271-4CFDA73B-E3A6-4AF2-883F-774212D08879

P932

Q35583271-26417A32-A618-419C-95BE-F644153CFB47

P356

J.DRUGALCDEP.2011.07.007

P1433

Drug and Alcohol Dependence

P1476

Modafinil for the treatment of methamphetamine dependence

@en

P2093

Ahmed M Elkashef

http://www.w3.org/2001/XMLSchema#string

Christopher Stock

http://www.w3.org/2001/XMLSchema#string

Dennis Weis

http://www.w3.org/2001/XMLSchema#string

Elmer Yu

http://www.w3.org/2001/XMLSchema#string

Erin Iturriaga

http://www.w3.org/2001/XMLSchema#string

Frances McSherry

http://www.w3.org/2001/XMLSchema#string

Jan Campbell

http://www.w3.org/2001/XMLSchema#string

Joseph Mawhinney

http://www.w3.org/2001/XMLSchema#string

Kousick Biswas

http://www.w3.org/2001/XMLSchema#string

Michael McCann

http://www.w3.org/2001/XMLSchema#string

P2860

Modafinil for the treatment of cocaine dependence

Dopaminergic role in stimulant-induced wakefulness.

Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years.

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

A systematic review of modafinil: Potential clinical uses and mechanisms of action.

Use of modafinil for the treatment of attention deficit/hyperactivity disorder.

Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.

P304

135-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2011.07.007

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51570043

http://www.w3.org/2001/XMLSchema#string

P698

21840138

http://www.w3.org/2001/XMLSchema#string

P921

P932

3227772

http://www.w3.org/2001/XMLSchema#string